CIK 0001160308 · Non-accelerated filer<br>Smaller reporting company
Savara Inc
Sign in to watch- Ticker
- SVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841318182
- Phone
- 51285113796
- Business address
- 6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
- Former names
- Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-13 | Hawkins Richard J Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2022-12-13 | Elam Nevan C Director | Option exercise | +1,172 | $0.65 | $762 | 29,244 |
| 2022-12-13 | Elam Nevan C Director | Option exercise · Stock Option (Right to Buy) | −1,172 | 0 | ||
| 2022-12-13 | Elam Nevan C Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2022-12-13 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Grant or award | +325,000 | 1,046,354 | ||
| 2022-12-13 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +700,000 | 700,000 | ||
| 2022-12-13 | Lowrance David L CHIEF FINANCIAL OFFICER | Grant or award | +100,000 | 242,793 | ||
| 2022-12-13 | Lowrance David L CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2022-12-13 | Sun Ricky Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2022-12-07 | Hawkins Richard J Director | Option exercise | +1,172 | $0.65 | $762 | 1,900 |
| 2022-12-07 | Hawkins Richard J Director | Option exercise · Stock Option (Right to Buy) | −1,172 | 0 | ||
| 2022-11-23 | RAMSAY DAVID A Director | Purchase | +4,610 | $1.44 | $7K | 1,946,252 |
| 2022-11-22 | RAMSAY DAVID A Director | Purchase | +15,495 | $1.42 | $22K | 1,941,642 |
| 2022-11-21 | Pratt Raymond Dennis Chief Medical Officer | Grant or award | +150,000 | 150,000 | ||
| 2022-11-21 | Pratt Raymond Dennis Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +375,000 | 375,000 | ||
| 2022-11-21 | RAMSAY DAVID A Director | Purchase | +25,005 | $1.42 | $36K | 1,926,147 |
| 2022-11-18 | RAMSAY DAVID A Director | Purchase | +16,100 | $1.34 | $22K | 1,901,142 |
| 2022-11-17 | RAMSAY DAVID A Director | Purchase | +8,900 | $1.27 | $11K | 1,885,042 |
| 2022-09-27 | RAMSAY DAVID A Director | Purchase | +73,893 | $1.37 | $101K | 1,876,142 |
| 2022-09-26 | RAMSAY DAVID A Director | Purchase | +31,107 | $1.38 | $43K | 1,802,249 |
Page 9 of 11 · 202 trades